×
Dr. Vijay Yeldandi-Infectious Diseases Specialist in Hyderabad

Dr. Vijay Yeldandi

MD, FACP, FCCP, FIDSA

Infectious Diseases Specialist

Specializations
  • Infectious Diseases Specialist
Qualifications
  • MBBS - Gandhi Medical College - 1982 - Hyderabad
  • Residency - Grant Hospital Of Chicago , Board Certified In Internal Medicine , ABIM - 1986
  • Fellowship Infectious Diseases - Loyola University of Chicago , Board Certified In Infectious Diseases - ABIM - 1988
  • Fellow - American College Of Physicians
  • Fellow - American College Of Chest Physicians
  • Fellow - Infectious Disease Society Of America
Experiences
  • Associate Director Clinical Research Abbott - 1999 - 2002
  • Program Director Internal Medicine Vanguard Westlake Hospital - 2005 - 2012
  • Chief Medical Officer Vanguard Westlake Hospital - 2010 - 2012
  • Faculty Public Health Foundation Of India - 2012
  • Director Transplant Infectious Diseases University Of Illinois At , Chicago - 2012 - 2017
  • Professor University Of Illinois - Chicago - 2012
  • Director Consultant for Immunology and Infectious Diseases International Center Human Health Advancement - Hyderabad - 2017
  • Faculty Center Global Health - University Of Illinois - Chicago - 2017
  • Consultant Infectious Diseases Specialist Virinchi Hospitals - Banjara Hills
  • Consultant Infectious Diseases Specialist Continental Hospitals - Gachibowli
  • Consultant Infectious Diseases Specialist GYD Health - Jubliee Hills - Currently Working
  • Consultant Infectious Diseases Specialist Century Hospital - Banjara Hills - Currently Working
Registrations
  • 9676 Telangana State Medical Council 1982
Awards and Recognitions
  • Literary Secretary 1978 - 1979 Gandhi Medical College
  • Intern of the Year 1983 - 1984 Grant Hospital of Chicago
  • Outstanding Resident - 1985 - 1986 Grant Hospital of Chicago
  • Golden Apple - 1992 Grant Hospital of Chicago
  • Silver Apple - 1994 Loyola University Medical Center, Department of Medicine
  • Bronze Apple - 1995 Loyola University Medical Center, Department of Medicine
  • Bronze Apple - 1996 Loyola University Medical Center, Department of Medicine
  • Golden Apple - 2003 Resurrection Westlake Residency Program
  • Most Distinguished Physician Award - 2005
  • Distinguished Physician Award - 2007
  • Golden Apple - 2008 Resurrection Westlake Residency Program
  • Award of Recognition for Outstanding Leadership, Resurrection Westlake Hospital - 2009
  • Vanguard Leadership Academy Graduated Feb 2012
Memberships
  • Society For Healthcare Epidemiology Of America
  • Association For Professionals In Infection Control And Epidemiology
  • International Society For Infectious Disease
  • American Association Of Physicians Of Indian Origin
  • Indian American Medical Association (Illinois)
  • HIV Medicine Association
  • International AIDS Society
  • American Society Of Transplantation
  • Clinical Infectious Diseases Society (India)
  • Indian Society Of Critical Care Medicine
  • American Association For The advancement Of science
  • International Society Of Human And Animal Mycology
  • Association For The Prevention And Control Of Rabies In India
  • American Society Of Professionals In Patient Safety
Paper Presentations
  • Principal Investigator Phase I. Study of the safety and pharmacokinetics of AmBisome® (liposomal amphotericin-B) in adults receiving Anti-Neoplastic therapy or Bone Marrow Transplantation- 1994
  • Principal Investigator Phase II/III. A Randomized double-blind comparative trial of AmBisome® (liposomal Amphotericin B) vs. Amphotericin B in the empiric treatment of the febrile neutropenic patient- 1995
  • Principal Investigator. Human cytomegalovirus disease in lung transplant recipients. A study of the epidemiology and pathogenicity of human cytomegalovirus strains causing interstitial pneumonia in lung transplant recipients. In collaboration with Nell S. Lurain- Ph.D. Rush Pres St Lukes Medical Center
  • Principal Investigator. AmBisome® Open Label Trial
  • Co-Investigator. A Randomized- Open Label- Comparative- Multicenter Trial of Voriconazole vs. AmBisome® for Empirical Antifungal Therapy in Immunocompromised Patients with Persistent Fever and Neutropenia. Protocol Number: 150-603. (Pfizer and MSG). Member: NIAID Mycoses Study Group 1996-1999
  • Co-Investigator. A Multi-Center- Double Blind

Report an error

Practice Locations

location-icon

Road No.12

Bhola Nagar

Banjara Hills, Hyderabad

Fee : ₹ 1200

google-maps-image

Get direction

time-icon

OP Timings

On Call

location-icon

Plot Number - 1278

Road Number -63 A, Suvarna Nilayam

Near Jubilee Check Post

Jubilee Hills, Hyderabad

Fee : ₹ 1200

google-maps-image

Get direction

time-icon

OP Timings

Mon - Sat 04:00 pm - 06:00 pm
No Reviews Found!
Write a review for Dr. Vijay Yeldandi

Which clinic or hospital you visited

I Recommend this Doctor for

Write your experience aboutDr. Vijay Yeldandi